Boston Oncology maintains a diverse and extensive portfolio of best-in-class generic and biosimilar therapeutics—USFDA / EMA registered and licensed from world-renowned innovator companies—supporting the entire patient journey.
We are very proud of our reputation for anticipating demand, and growing our portfolio with precision. Our products include the most widely used formulations in critical care, oncology, and pain relief—offering a comprehensive solution to healthcare providers and hospitals.
Leveraging our Global footprint and extensive International experience, Boston Oncology is able to secure licensing agreements for the best formulations in the US and European markets. We deliver products of unparalleled quality by creating modular and highly flexible local manufacturing facilities, sourcing API from the same batches manufactured for the US and European markets; and even pursuing regional approvals using the same files submitted for the original USFDA / EMA registration.
Boston Oncology is aggressively pursuing a research and development program to offer next generation treatments through critical care medicines, specialty generics, oncology products, orphan drugs, and narcotics.
Birato | 250 mg, 500 mg | Tablet
Bortezomib BOS | 3.5 mg | Powder for solution for injection
Emcap | 500 mg | Tablet
Allbloc | 1 mg/mL | Concentrate for solution for infusion
Tykodas | 50 mg, 70 mg, 100 mg | Film-coated tablet
Docadex | 20 mg, 80 mg | Concentrate for solution for infusion
Gemcitabine BOS | 1000 mg | Concentrate for solution for infusion
Citarox | 1000 mg, 200 mg | Powder for solution for injection
Tecana | 20 mg/mL | Powder for solution for injection
Lenvatinib TBM | 10 mg | Capsule
Xorola | 2.5 mg | Film-coated tablet
Batipan | 50 mg, 100 mg | Powder for solution for injection
Pemitax | 500 mg | Powder for solution for injection
Sorafenat | 200 mg | Film-coated tablet
Apeto | 15 mg, 100 mg | Powder for solution for injection
Sermitor | 60 mg | Tablet
Demexa | 100 mcg | Solution for injection
Milrinone BOS | 1 mg/mL | Solution for injection
Ketorolac BOS | 30 mg/mL | Solution for injection
Tranexamic Acid BOS | 100 mg | Powder for solution for injection
Rocuronium BOS | 10 mg/mL | Solution for injection
Ferasiro | 90 mg, 180 mg, 360 mg | Film-coated tablet
Envona | 150 mg | Powder for solution for infusion
Levetiracetam TBM | 100 mg | Injection
Teriflunomide BOS | 14 mg | Film-coated tablet
Hemabo | 24 mg/mL | Solution for injection
Fenido | 267 mg, 801 mg | Film-coated tablet
Acidoxax | 4 mg | Concentrate for solution for infusion
Anidulafungin BOS | 100 mg | Powder for concentrate for solution
Azithromycin TBM | 500 mg | Powder for solution for injection
Copsfin | 50 mg, 70 mg | Powder for concentrate for solution
Daptomycin BOS | 350 mg | Powder for solution for injection or infusion
Foscarnet BOS | 24 mg/mL | Solution for infusion
Oselow | 75 mg | Capsule
Tigecycline BOS | 50 mg/vial | Powder for infusion
Voriole | 200 mg | Powder for solution for infusion
Enoxaparin BOS | 20 mg, 40 mg, 60 mg, 80 mg | Solution for injection
